Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-16T10:00:09.240Z Has data issue: false hasContentIssue false

Chronic tendon pathology: molecular basis and therapeutic implications

Published online by Cambridge University Press:  30 March 2005

Graham Riley
Affiliation:
Rheumatology Research Unit, Box 194, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Tendons are frequently affected by chronic pain or rupture. Many causative factors have been implicated in the pathology, which until relatively recently was under-researched and poorly understood. There is now a greater knowledge of the molecular basis of tendon disease. Most tendon pathology (tendinopathy) is associated with degeneration, which is thought to be an active, cell-mediated process involving increased turnover and remodelling of the tendon extracellular matrix. Degradation of the tendon matrix is mediated by a variety of metalloproteinase enzymes, including matrix metalloproteinases and ‘aggrecanases’. Neuropeptides and other factors released by stimulated cells or nerve endings in or around the tendon might influence matrix turnover, and could provide novel targets for therapeutic intervention.

Information

Type
Review Article
Copyright
© Cambridge University Press 2005